Aarti Drugs Ltd Board of Directors

Home

Insights

Board of Directors

₹ 0.2 Cr

Volume transacted

4.5 K

stocks traded

Last Updated time: 19 Sep 9.00 AM

Board of Directors

Name	Designation

Prakash M Patil	CMD & Executive Director
Rashesh C Gogri	ED / MD / Promoter
Harshit M Savla	ED / Joint MD / Promoter
Harit P Shah	E D & Wholetime Director
Uday M Patil	WTD & Executive Director

name	designation
Prakash M Patil	CMD & Executive Director
Rashesh C Gogri	ED / MD / Promoter
Harshit M Savla	ED / Joint MD / Promoter
Harit P Shah	E D & Wholetime Director
Uday M Patil	WTD & Executive Director

Open Demat Account

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Key Highlights

Prakash M Patil joins the board as CMD & Executive Director, in a new position in 2023. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Rashesh C Gogri joins the board as ED / MD / Promoter, in a new position in 2023. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Harshit M Savla joins the board as ED / Joint MD / Promoter, in a new position in 2023. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Harit P Shah joins the board as E D & Wholetime Director, in a new position in 2023. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Uday M Patil joins the board as WTD & Executive Director, in a new position in 2023. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.

Aarti Drugs Ltd

NSE: AARTIDRUGS

PRICE

Last updated:

Last Ten Days Share Price

Date	Price	Day Open	Day High	Day Low

19 Sep 2024	518.8	529.9	529.9	517.3
18 Sep 2024	524.85	529.05	531.2	523
17 Sep 2024	529.8	534.85	536.55	528
16 Sep 2024	529.65	527.35	531.9	521.6
13 Sep 2024	524.75	530	532.75	523.25
12 Sep 2024	527.05	530.05	539.9	520.85
11 Sep 2024	529	544.85	551.95	526.5
10 Sep 2024	539.85	559.65	559.65	538.3
09 Sep 2024	544.7	550	553.55	538.25
06 Sep 2024	553.65	565	568.75	551

Date	Price
19 Sep 2024	518.8
18 Sep 2024	524.85
17 Sep 2024	529.8
16 Sep 2024	529.65
13 Sep 2024	524.75
12 Sep 2024	527.05
11 Sep 2024	529
10 Sep 2024	539.85
09 Sep 2024	544.7
06 Sep 2024	553.65

Company Fundamentals for Aarti Drugs Ltd

Market Cap

₹ 4,769 Cr

EPS

₹ 17.1

P/E Ratio (TTM) *

30.4

P/B Ratio (TTM) *

3.7

Day’s High *

529.9

Day’s Low

₹ 517.3

DTE *

0.4

ROE *

13.4

52 Week High

₹ 634.9

52 Week Low

₹ 430.0

ROCE *

14.6

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

Monitoring Aarti Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Aarti Drugs Ltd News Hub

Aarti Drugs extends buyback offer period

Aarti Drugs announced that the bidding process of buyback offer will remain open on Monday...

16 Sep 202408:52

Aarti Drugs AGM scheduled

Aarti Drugs announced that the Annual General Meeting (AGM) of the company will be held on...

03 Sep 202411:38

Board of Aarti Drugs approves buyback of shares up to Rs 59.85 cr

The Board of Aarti Drugs at its meeting held on 26 August 2024 has approved buyback of up ...

26 Aug 202417:17

Aarti Drugs hit 52-week high as board OKs Rs 60-cr share buyback

The buyback price fixed at Rs 900 per equity share, representing a 59.66% premium to Frida...

26 Aug 202416:35

Aarti Drugs to consider buyback

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 26 August 2024...

22 Aug 202410:50

Aarti Drugs soars on share buyback proposal

The announcement was made after market hours yesterday. Aarti Drugs forms part of $6 Billi...

22 Aug 202411:17

Document

Annual Reports

N/A

Credit Ratings

N/A

Concalls

Popular Search

Aarti Drugs Ltd share holding pattern

Aarti Drugs Ltd market cap

Aarti Drugs Ltd share price history

Aarti Drugs Ltd isin code

Sun Pharmaceuticals Industries Ltd board of directors

Divis Laboratories Ltd board of directors

Cipla Ltd board of directors

Torrent Pharmaceuticals Ltd board of directors

Dr Reddys Laboratories Ltd board of directors

Zydus Lifesciences Ltd board of directors

Lupin Ltd board of directors

Mankind Pharma Ltd board of directors

Aurobindo Pharma Ltd board of directors

Alkem Laboratories Ltd board of directors

FAQs for Board of Directors of Aarti Drugs Ltd

How are members of Aarti Drugs Ltd Board of Directors selected?

Members of the Aarti Drugs Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Aarti Drugs Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.

Can shareholders interact with the Aarti Drugs Ltd Board of Directors?

Shareholders can interact with the Aarti Drugs Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.

How often does the Aarti Drugs Ltd Board of Directors meet?

The Aarti Drugs Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.

What are the responsibilities of the Aarti Drugs Ltd Board of Directors?

The Aarti Drugs Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.

Who are the current members of the Board of Directors at Aarti Drugs Ltd?

The current Board of Directors at Aarti Drugs Ltd includes Prakash M Patil( CMD & Executive Director) ,Rashesh C Gogri( ED / MD / Promoter) ,Harshit M Savla( ED / Joint MD / Promoter) ,Harit P Shah( E D & Wholetime Director) ,Uday M Patil( WTD & Executive Director) . The full list can be found on Aarti Drugs Ltd’s official website or recent corporate filings.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*